Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Thermo Fisher Scientific Inc., consolidated balance sheet: assets (quarterly data)

US$ in millions

	Jun 28, 2025	Mar 29, 2025	Dec 31, 2024	Sep 28, 2024	Jun 29, 2024	Mar 30, 2024	Dec 31, 2023	Sep 30, 2023	Jul 1, 2023	Apr 1, 2023	Dec 31, 2022	Oct 1, 2022	Jul 2, 2022	Apr 2, 2022	Dec 31, 2021	Oct 2, 2021	Jul 3, 2021	Apr 3, 2021	Dec 31, 2020	Sep 26, 2020	Jun 27, 2020	Mar 28, 2020
Cash and cash equivalents	4,576)	4,134)	4,009)	4,645)	7,073)	5,499)	8,077)	6,151)	3,133)	3,482)	8,524)	2,919)	1,888)	2,752)	4,477)	12,027)	7,023)	5,583)	10,325)	7,540)	5,818)	2,981)
Short-term investments	1,814)	1,813)	1,561)	2,000)	1,750)	1,751)	3)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Accounts receivable, less allowances	8,594)	8,455)	8,191)	8,255)	7,943)	7,931)	8,221)	8,370)	8,019)	7,922)	8,115)	7,671)	7,745)	7,889)	7,977)	5,557)	5,476)	5,554)	5,741)	5,186)	4,478)	4,508)
Inventories	5,559)	5,224)	4,978)	5,430)	5,198)	5,133)	5,088)	5,404)	5,655)	5,664)	5,634)	5,722)	5,668)	5,483)	5,051)	4,906)	4,625)	4,342)	4,029)	3,829)	3,648)	3,454)
Contract assets, net	1,441)	1,366)	1,435)	1,541)	1,487)	1,422)	1,443)	1,465)	1,467)	1,375)	1,312)	1,248)	1,147)	1,064)	968)	808)	804)	783)	731)	697)	686)	658)
Other current assets	2,600)	2,386)	1,963)	1,912)	2,025)	1,904)	1,757)	1,702)	1,721)	1,766)	1,644)	1,739)	1,652)	1,588)	1,640)	1,426)	1,332)	1,423)	1,131)	982)	1,145)	1,137)
Current assets	24,584)	23,378)	22,137)	23,783)	25,476)	23,640)	24,589)	23,092)	19,995)	20,209)	25,229)	19,299)	18,100)	18,776)	20,113)	24,724)	19,260)	17,685)	21,957)	18,234)	15,775)	12,738)
Property, plant and equipment, net	9,635)	9,331)	9,306)	9,412)	9,282)	9,324)	9,448)	9,167)	9,292)	9,354)	9,280)	8,628)	8,529)	8,448)	8,333)	7,049)	6,560)	6,133)	5,912)	5,180)	4,887)	4,736)
Acquisition-related intangible assets, net	15,148)	15,323)	15,533)	16,262)	15,519)	16,048)	16,670)	17,091)	17,437)	17,972)	17,442)	17,813)	18,578)	19,378)	20,113)	11,927)	12,390)	12,831)	12,685)	12,870)	13,170)	13,543)
Other assets	4,614)	4,516)	4,492)	4,181)	4,376)	4,240)	3,999)	4,124)	4,108)	3,983)	4,007)	4,308)	4,306)	4,424)	4,640)	2,991)	2,584)	2,459)	2,457)	1,995)	2,061)	2,057)
Goodwill	47,249)	46,493)	45,853)	46,726)	43,843)	43,843)	44,020)	43,583)	43,273)	43,140)	41,196)	40,488)	41,066)	41,721)	41,924)	26,909)	26,904)	26,823)	26,041)	25,782)	25,700)	25,614)
Long-term assets	76,646)	75,663)	75,184)	76,581)	73,020)	73,455)	74,137)	73,965)	74,110)	74,449)	71,925)	71,237)	72,479)	73,971)	75,010)	48,876)	48,438)	48,246)	47,095)	45,827)	45,818)	45,950)
Total assets	101,230)	99,041)	97,321)	100,364)	98,496)	97,095)	98,726)	97,057)	94,105)	94,658)	97,154)	90,536)	90,579)	92,747)	95,123)	73,600)	67,698)	65,931)	69,052)	64,061)	61,593)	58,688)

Cash and Cash Equivalents: The cash and cash equivalents demonstrated volatility over the periods, with a sharp increase in the middle of 2020 reaching a peak of 10,325 million USD in Dec 31, 2020, followed by a significant drop to a low of 1,888 million USD by Jul 2, 2022. After this trough, cash levels gradually increased again, reaching 8,077 million USD by Dec 31, 2023, but subsequent quarters show fluctuations, with decreases in early 2024 and stabilization near 4,500 million USD by Jun 28, 2025.
Short-term Investments: Short-term investments data are sparse and only reported from early 2024, showing a growing trend from 3 million USD in Mar 30, 2024 to above 1,800 million USD by Jun 28, 2025, suggesting an increased allocation of liquid assets to short-term instruments during this later period.
Accounts Receivable, Less Allowances: Accounts receivable gradually increased from 4,508 million USD in Mar 28, 2020 to over 8,500 million USD by the end of the observed period. Notable growth took place in late 2020 and throughout 2021, followed by a plateau and minor fluctuations in subsequent years, indicating stable credit sales and collections.
Inventories: Inventories showed an increasing trend from 3,454 million USD in early 2020 to a peak of about 5,722 million USD by Oct 1, 2022, followed by a decline and then variability in later quarters, ending at 5,559 million USD in mid-2025. This indicates expansion in inventory holdings aligned with business growth, followed by adjustments and inventory management efforts.
Contract Assets, Net: Contract assets displayed steady growth throughout the periods, increasing from 658 million USD in early 2020 to around 1,440 million USD by mid-2025. This gradual increase implies stronger contract fulfillment and associated revenue recognition over time.
Other Current Assets: Other current assets increased moderately over time, rising from roughly 1,137 million USD to over 2,600 million USD by mid-2025. This upward trend signals increasing miscellaneous current assets, supporting overall current asset growth.
Current Assets: Current assets exhibited considerable variation, with a significant rise from 12,738 million USD in early 2020 to a peak of 25,229 million USD by Dec 31, 2022, followed by some declines and rebounds in subsequent quarters. This reflects the dynamics in cash, receivables, inventories, and other short-term assets, indicating fluctuations in liquidity and operational asset management.
Property, Plant and Equipment, Net: The net value of property, plant, and equipment showed a steady upward trend, growing from 4,736 million USD in early 2020 to 9,635 million USD by mid-2025, reflecting ongoing capital expenditures and investment in fixed assets to support business growth.
Acquisition-related Intangible Assets, Net: Acquisition-related intangible assets generally decreased from 13,543 million USD at the start of the period to 15,148 million USD by mid-2025, with a peak near 20,113 million USD at Dec 31, 2021. The overall decrease likely reflects amortization and impairment effects mitigating earlier acquisition values, with some fluctuations indicating new acquisitions or revaluations.
Other Assets: Other assets increased from about 2,057 million USD in early 2020 to 4,614 million USD by mid-2025, with some variances along the timeline. This suggests growth in non-current miscellaneous assets supporting the balance sheet structure.
Goodwill: Goodwill displayed a notable increase from 25,614 million USD in early 2020 to 47,249 million USD by mid-2025, with a sharp rise occurring around Dec 31, 2021. This indicates significant merger and acquisition activity, with sustained goodwill values reflecting investments in business acquisitions.
Long-term Assets: Long-term assets followed an upward trajectory, starting at 45,950 million USD and increasing to approximately 76,646 million USD by mid-2025. The trend shows consistent asset base growth, supporting long-term business expansion.
Total Assets: Total assets rose from 58,688 million USD in early 2020 to over 101,000 million USD by mid-2025, with a pronounced spike reported at the end of 2021. This overall upward trend reflects successful asset accumulation through operational growth, acquisitions, and capital investments.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Thermo Fisher Scientific Inc. (NYSE:TMO)

Balance Sheet: Assets Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data